Nunzia Pharmaceutical CorpOver The Counter Market:NUNZ
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nunzia Pharmaceutical Corp | 430.0 | 0.0x | --- |
Neutra Corp | 291.8K | -1.7x | --- |
PharmaRoth Labs Inc | 390.0 | 0.0x | --- |
Pilot Therapeutics Holdings Inc | 1.2K | 0.0x | --- |
Earth Life Sciences Inc | 100.0K | -0.2x | --- |
Calithera Biosciences Inc | 29.2K | 0.0x | --- |
Company Information
Nunzia Pharmaceutical Corporation is a pharmaceutical company. The Company focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The Company has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.
Contact Information
- Headquarters
- 1627 WEST 14TH STREETLONG BEACH, CA, United States 90813
- Phone
- 714-609-9117
- Fax
- 972-386-7864
Executives
- Chairman of the Board, Chief Executive Officer
- R. Steve Mills
- Chief Financial Officer, Vice President
- Kingman Hitz
- Chief Financial Officer, Senior Vice President, Secretary, Treasurer
- Roger Kron
- Director
- G.David Henry
- Director
- Mary Pohlmeier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $430.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 434.5M |
Nunzia Pharmaceutical Corp does not pay a dividend. | |
Beta | -2.47 |
EPS | $-0.22 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
